Investing Ideas
/
U.S. Healthcare Potentially Undervalued Companies

U.S. Healthcare Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

256

6 new

Companies with a Value score of at least 3, ordered by Value score

256 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ENOV Enovis	US$47.02	2.8%	-19.9%	US$2.7b	US$66.00	PS1.3x	E109.5%	n/a
CON Concentra Group Holdings Parent	US$22.14	6.2%	n/a	US$2.8b	US$27.50	PE16.3x	E4.2%	1.1%
THC Tenet Healthcare	US$134.42	3.4%	68.8%	US$12.8b	US$177.96	PE4.1x	E-30.2%	n/a
BLCO Bausch + Lomb	US$17.07	-1.2%	19.5%	US$6.1b	US$20.80	PS1.3x	E58.6%	n/a
LNTH Lantheus Holdings	US$95.39	2.1%	86.8%	US$6.5b	US$134.69	PE15.5x	E12.8%	n/a
ELV Elevance Health	US$390.73	0.4%	-17.5%	US$90.3b	US$496.65	PE14.1x	E11.0%	1.7%
CNC Centene	US$63.53	0.6%	-15.8%	US$32.1b	US$79.45	PE10.5x	E3.3%	n/a
HAE Haemonetics	US$73.35	-2.3%	-10.3%	US$3.8b	US$110.80	PE29.8x	E24.2%	n/a
BVS Bioventus	US$10.09	3.9%	133.0%	US$668.7m	US$15.00	PS1.2x	E110.7%	n/a
SRTS Sensus Healthcare	US$6.99	3.2%	98.6%	US$112.1m	US$11.50	PE12.3x	E26.0%	n/a
HCA HCA Healthcare	US$319.51	4.3%	14.5%	US$80.7b	US$388.53	PE13.7x	E5.9%	0.8%
UHS Universal Health Services	US$187.03	1.9%	22.0%	US$12.5b	US$237.54	PE12x	E8.2%	0.4%
SNNU.F Smith & Nephew	US$13.15	11.9%	-4.0%	US$9.0b	US$16.33	PE36.6x	E22.6%	2.9%
SGRY Surgery Partners	US$20.35	0.6%	-33.8%	US$2.6b	US$34.00	PS0.9x	E83.6%	n/a
ICUI ICU Medical	US$167.01	0.2%	79.3%	US$4.1b	US$203.40	PS1.7x	E73.7%	n/a
OPRX OptimizeRx	US$5.43	9.9%	-63.5%	US$99.7m	US$9.64	PS1.1x	E51.5%	n/a
GNGB.Y Getinge	US$18.01	7.1%	-14.8%	US$53.8b	US$19.96	PE32x	E21.8%	2.2%
AMWL American Well	US$10.29	22.1%	-53.6%	US$168.2m	US$11.21	PS0.6x	E54.4%	n/a
TVTY Tivity Health	US$32.50	0.4%	22.2%	US$1.6b	US$30.17	PE18.4x	E12.5%	n/a
SHHP.F Ship Healthcare Holdings	US$13.84	0%	n/a	US$202.9b	US$20.62	PE12.9x	E10.2%	2.5%
MODV ModivCare	US$5.42	-23.9%	-87.3%	US$84.8m	US$12.38	PS0.03x	E55.3%	n/a
SHTD.Y Sinopharm Group	US$13.04	0.9%	6.2%	US$63.3b	US$15.27	PE6.8x	E4.4%	4.5%
TRIB Trinity Biotech	US$0.77	-3.2%	-62.3%	US$14.0m	n/a	PS0.2x	E33.2%	0%
EMBC Embecta	US$18.74	-3.4%	11.1%	US$1.1b	US$22.00	PE13.9x	E29.3%	3.2%

Page 1 of 11